PCK2 and non-small cell lung carcinoma: Taken together, these data showed that PCK2-mediated gluconeogenesis is required to reduce the accumulation of TCA cycle metabolites and the level of oxidative phosphorylation, which in turn decreases mtROS production and apoptotic cell death of NSCLC cells upon glucose restriction.